UBX
Dimensional Fund Advisors’s Unity Biotechnology UBX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-11,120
| Closed | -$11.6K | – | 3332 |
|
|
2025
Q1 | $11.6K | Buy |
+11,120
| New | +$11.6K | ﹤0.01% | 3314 |
|
|
2024
Q1 | – | Sell |
-25,500
| Closed | -$49.2K | – | 3432 |
|
|
2023
Q4 | $49.2K | Sell |
25,500
-14,219
| -36% | -$27.4K | ﹤0.01% | 3346 |
|
|
2023
Q3 | $95.3K | Sell |
39,719
-21,228
| -35% | -$50.9K | ﹤0.01% | 3319 |
|
|
2023
Q2 | $155K | Sell |
60,947
-6,952
| -10% | -$17.7K | ﹤0.01% | 3274 |
|
|
2023
Q1 | $111K | Buy |
67,899
+37,473
| +123% | +$61.1K | ﹤0.01% | 3289 |
|
|
2022
Q4 | $83 | Buy |
+30,426
| New | +$83 | ﹤0.01% | 3348 |
|
|
2022
Q1 | – | Sell |
-36,171
| Closed | -$53K | – | 3557 |
|
|
2021
Q4 | $53K | Buy |
36,171
+506
| +1% | +$741 | ﹤0.01% | 3492 |
|
|
2021
Q3 | $107K | Sell |
35,665
-13,335
| -27% | -$40K | ﹤0.01% | 3421 |
|
|
2021
Q2 | $227K | Buy |
49,000
+336
| +0.7% | +$1.56K | ﹤0.01% | 3316 |
|
|
2021
Q1 | $292K | Buy |
+48,664
| New | +$292K | ﹤0.01% | 3232 |
|